Canada markets open in 8 hours 3 minutes

Kiromic BioPharma, Inc. (KRBP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.2300+0.1300 (+4.19%)
At close: 02:32PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.16M
Enterprise Value 14.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)11.55
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.13

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-20.44%
S&P500 52-Week Change 329.31%
52 Week High 34.3400
52 Week Low 30.1600
50-Day Moving Average 32.6494
200-Day Moving Average 31.5460

Share Statistics

Avg Vol (3 month) 33.72k
Avg Vol (10 day) 32.99k
Shares Outstanding 51.29M
Implied Shares Outstanding 61.29M
Float 8963.16k
% Held by Insiders 118.90%
% Held by Institutions 10.00%
Shares Short (Aug 31, 2023) 445.74k
Short Ratio (Aug 31, 2023) 41.45
Short % of Float (Aug 31, 2023) 46.82%
Short % of Shares Outstanding (Aug 31, 2023) 43.89%
Shares Short (prior month Jul 31, 2023) 462.44k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Mar 13, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-98.48%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.05M
Net Income Avi to Common (ttm)-24.35M
Diluted EPS (ttm)-7.4200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.68M
Total Cash Per Share (mrq)2.82
Total Debt (mrq)13.58M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.29
Book Value Per Share (mrq)-5.53

Cash Flow Statement

Operating Cash Flow (ttm)-22.8M
Levered Free Cash Flow (ttm)-15.57M